Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for MAGNEVIST
- Efficacy of Dotarem® (Gd-DOTA) Versus Gadovist® (Gd-DO3A-butrol) for Late Gadolinium Enhancement Cardiac Magnetic Resonance
- Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases
- Stress Cardiac MRI for Evaluation of Nonspecific Allograft Dysfunction
- Unilateral Meniere Disease: Can Double Dose Gadolinium and Delayed Imaging Make the Diagnosis?
- Magnetic Resonance Imaging of Interscalene Plexus Block
- Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions
- Proton MR Spectroscopy and 18F-Fluorocholine PET for Breast Cancer Diagnosis
- Influence of the OATP1B1 and OATP1B3 Genotype on the Hepatic Uptake of Primovist®
- A Comparison of Indirect and Direct MR Arthrography of the Shoulder Using Arthroscopic Correlation
- Magnevist Post-marketing Surveillance in Japan
- Crossover Comparison of Two Gadolinium Contrast Agents for Use With MRA of Carotid, Renal and Peripheral Arteries
- Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions
- Gadobutrol Magnevist-controlled Body Study
- Molecular Imaging With Erlotinib and Bevacizumab
- Contrast-enhanced MRI in Children 2 Months to <2 Years
- Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Moderate Renal Insufficiency After the Administration of Magnevist
- Magnevist (SH L 451A) Intra-individual Dose Comparison Study in Patients With Brain Metastasis
- Magnevist (SH L 451A) Intra-individual Dose Comparison Study in Magnetic Resonance Angiography
- Multihance Versus Magnevist in Breast MRI
- Crossover Study With MultiHance vs a Comparator for Peripheral MRA
- Multihance at 3 Tesla (3T) in Brain Tumors
- Efficacy and Safety Study to Evaluate Gadavist (Gadobutrol) as Contrast Agent in Magnetic Resonance Imaging (MRI) of Vascular Diseases in Chinese Patients
- Efficacy and Safety Study to Evaluate Gadavist (Gadobutrol) as Contrast Agent in Magnetic Resonance Imaging (MRI) of Brain or Spine Diseases in Chinese Patients
- Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases
- Magnevist® Injection Enhanced MRA Compared to Non Contrast MRA for the Detection of Structural Abnormalities of the Aortic Arch and Cerebral Branches
- Cardiovascular Safety Study of Magnevist® Injection at Two Dose Levels and Two Injection Rates in Normal Subjects
- Magnevist® Injection-enhanced MRA Compared to Non Contrast MRA for the Detection of Stenosis of the Renal Arteries
- Depiction of Delayed Enhancement in Patients With Documented Myocardial Infarction
- Magnevist® Injection Enhanced MRA Compared to Non Contrast MRA for the Detection of Stenosis in the Calf and/or Pedal Arteries
- Magnevist® Injection Enhanced MRA at Two Dose Levels Compared to Non Contrast MRA for the Detection of Structural Abnormalities of the Infrarenal Aorta and Peripheral Arteries
Clinical trials list
click for details